X4 Pharmaceuticals, Inc. XFOR NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

53/100

2/7 Pass

SharesGrow Intrinsic Value

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Balance sheet is a point-in-time snapshot. TTM shows the most recent available quarter.

Metric	Latest Quarter (2025-12)
Total Assets	$290.46M
Total Liabilities	$104.17M
Total Debt	$77.29M
Cash & Investments	$253M
Total Stockholders Equity	$186.29M

People Also View

TERN

Terns Pharmaceuticals, Inc.

$52.71

+0.06%

DAWN

Day One Biopharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc.

$2.72

+1.49%

PDSB

PDS Biotechnology Corporation

$1.36

+28.30%

MREO

Mereo BioPharma Group plc

$0.34

+2.98%

ELEV

Elevation Oncology, Inc.

X4 Pharmaceuticals, Inc. XFOR NASDAQ

People Also View

Get Undervalued Stock Alerts